
Kyntra Bio, Inc.
KYNBHealthcare|Biotechnology|US
$3.73
+0.07 (+1.91%)
DCF Value
$12.09
Cash / Share
$22.56
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (3)
Jul 2027
Est. completion
P1P2Metastatic Castration-resistant Prostate Cancer
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
NCT05011188n=44
Mar 2028
Est. completion
P2Metastatic Castration-Resistant Prostate Cancer
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06842498n=75
Sep 2029
Est. completion
Recent Press Releases
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
Oct 1, 2026 · GlobeNewsWire
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 2, 2026 · GlobeNewsWire
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
Aug 31, 2026 · GlobeNewsWire
Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 13, 2026 · GlobeNewsWire
SEC Filings (58)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Oct 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 31, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 9, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 27, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 9, 2026 | 8-K | Material event | DocumentIndex |
| Mar 16, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 16, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 7, 2026 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 10, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 10, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Sep 5, 2025 | 8-K | Material event | DocumentIndex |
| Sep 2, 2025 | 8-K | Material event | DocumentIndex |
| Aug 18, 2025 | 8-K | Material event | DocumentIndex |
| Aug 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2025 | 8-K | Material event | DocumentIndex |
| Aug 11, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2025 | 8-K | Material event | DocumentIndex |
| Jul 29, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 14, 2025 | 8-K | Material event | DocumentIndex |
| Jun 13, 2025 | 8-K | Material event | DocumentIndex |
| Jun 12, 2025 | 8-K | Material event | DocumentIndex |
| Jun 9, 2025 | 8-K | Material event | DocumentIndex |
| May 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2025 | 8-K | Material event | DocumentIndex |
| Apr 25, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 25, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |